Inventor
DOBIE KENNETH W
US68 patents
⚠️ This page may combine multiple inventors who share the name “DOBIE KENNETH W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
31 patentsUS7732590B2Jun 8, 2010
Modulation of diacylglycerol acyltransferase 2 expression
ISIS PHARMACEUTICALS INC132 citations99
US7468431B2Dec 23, 2008
Modulation of eIF4E-BP2 expression
ISIS PHARMACEUTICALS INC117 citations99
US7399853B2Jul 15, 2008
Modulation of glucagon receptor expression
ISIS PHARMACEUTICALS INC105 citations99
US7217572B2May 15, 2007
Modulation of HIF1α and HIF2α expression
ISIS PHARMACEUTICALS INC139 citations99
US7144999B2Dec 5, 2006
Modulation of hypoxia-inducible factor 1 alpha expression
ISIS PHARMACEUTICALS INC115 citations99
US7750141B2Jul 6, 2010
Modulation of apolipoprotein c-III expression
ISIS PHARMACEUTICALS INC64 citations98
US7598227B2Oct 6, 2009
Modulation of apolipoprotein C-III expression
ISIS PHARMACEUTICALS INC292 citations98
US7199107B2Apr 3, 2007
Antisense modulation of kinesin-like 1 expression
ISIS PHARMACEUTICALS INC128 citations98
US7902163B2Mar 8, 2011
Antisense modulation of superoxide dismutase 1, soluble expression
ISIS PHARMACEUTICALS INC34 citations96
US7229976B2Jun 12, 2007
Modulation of forkhead box O1A expression
ISIS PHARMACEUTICALS INC114 citations96
US6617162B2Sep 9, 2003
Antisense modulation of estrogen receptor alpha expression
ISIS PHARMACEUTICALS INC57 citations96
US6716627B2Apr 6, 2004
Antisense modulation of mucin 1, transmembrane expression
ISIS PHARMACEUTICALS INC27 citations93
US7507808B2Mar 24, 2009
Modulation of endothelial lipase expression
ISIS PHARMACEUTICALS INC17 citations84
US6852536B2Feb 8, 2005
Antisense modulation of CD36L 1 expression
ISIS PHARMACEUTICALS INC15 citations84
US7163927B2Jan 16, 2007
Antisense modulation of kinesin-like 1 expression
ISIS PHARMACEUTICALS INC11 citations83
US8017760B2Sep 13, 2011
Antisense modulation of PTP1B expression
ISIS PHARMACEUTICALS INC4 citations74
US7803781B2Sep 28, 2010
Modulation of growth hormone receptor expression and insulin-like growth factor expression
ISIS PHARMACEUTICALS INC5 citations74
US7759479B1Jul 20, 2010
Compositions and their uses directed to Gemin Genes
ISIS PHARMACEUTICALS INC5 citations74
US6743909B2Jun 1, 2004
Antisense modulation of PTPN12 expression
ISIS PHARMACEUTICALS INC9 citations74
US7718628B2May 18, 2010
Antisense modulation of kinesin-like 1 expression
ISIS PHARMACEUTICALS INC4 citations73
US7807649B2Oct 5, 2010
Modulation of forkhead box O1A expression
ISIS PHARMACEUTICALS INC4 citations72
US6828151B2Dec 7, 2004
Antisense modulation of hematopoietic cell protein tyrosine kinase expression
ISIS PHARMACEUTICALS INC10 citations72
US9139831B2Sep 22, 2015
Modulation of angiopoietin-like 3 expression
ISIS PHARMACEUTICALS INC3 citations63
US7825235B2Nov 2, 2010
Modulation of diacylglycerol acyltransferase 2 expression
ISIS PHARMACEUTICALS INC1 citations63
US7585968B2Sep 8, 2009
Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
ISIS PHARMACEUTICALS INC4 citations63
US8865884B2Oct 21, 2014
Antisense modulation of kinesin-like 1 expression
ISIS PHARMACEUTICALS INC1 citations62
US7981868B2Jul 19, 2011
Antisense modulation of p38 mitogen activated protein kinase expression
ISIS PHARMACEUTICALS INC3 citations62
US7897583B2Mar 1, 2011
Compositions and their uses directed to PTPRU
ISIS PHARMACEUTICALS INC4 citations62
US7960358B2Jun 14, 2011
Antisense modulation of stearoyl-CoA desaturase expression
ISIS PHARMACEUTICALS INC3 citations60
US7618947B2Nov 17, 2009
Modulation of HIF-1 beta expression
ISIS PHARMACEUTICALS INC4 citations60
US7563885B1Jul 21, 2009
Modulation of Tudor-SN expression
ISIS PHARMACEUTICALS INC2 citations60
BENNETT C FRANK
5 patentsUS8258109B2Sep 4, 2012
Compositions and methods for modulation of LMNA expression
BENNETT C FRANK44 citations98
US8993529B2Mar 31, 2015
Antisense modulation of superoxide dismutase 1, soluble expression
BENNETT C FRANK12 citations93
US8921331B2Dec 30, 2014
Methods for slowing familial ALS disease progression
BENNETT C FRANK7 citations84
US8791088B2Jul 29, 2014
Compositions and methods for modulation of LMNA expression
BENNETT C FRANK6 citations84
US8669102B2Mar 11, 2014
Modulation of prion expression
BENNETT C FRANK5 citations73
IONIS PHARMACEUTICALS INC
3 patentsUS9624496B2Apr 18, 2017
Modulation of apolipoprotein C-III expression
IONIS PHARMACEUTICALS INC3 citations84
US9476051B2Oct 25, 2016
Antisense modulation of superoxide dismutase 1, soluble expression
IONIS PHARMACEUTICALS INC5 citations84
US11225664B2Jan 18, 2022
Modulation of angiopoietin-like 3 expression
IONIS PHARMACEUTICALS INC0 citations63
DOBIE KENNETH W
3 patentsTACHAS GEORGE
2 patentsCROOKE ROSANNE M
1 patentBHANOT SANJAY
1 patentMULLICK ADAM
1 patentIONIS PHARMACEUTICLS INC
1 patentFREIER SUSAN M
1 patentANTISENSE THERAPEUTICS LTD
1 patentShowing the top 50 of 68 patents by PatentIndex Score.